Vildagliptin structure
Vildagliptin
Vildagliptin (LAF-237; NVP-LAF 237) inhibits DPP-4 with IC50 of 2.3 nM.IC50 Value: 2.3 nM[1]Target: DPP-4in vitro: Vildagliptin is an N-substituted glycyl-2-cyanopyrrolidine (figure 2). It is a potent competitive and reversible inhibitor of human and rodent DPP-4 in vitro, with a median inhibitory concentration (IC50) ~2-3 nmol/L. Importantly, vildagliptin inhibits DPP-4 with high specificity relative to other similar peptidases where its IC50 exceeds 200 mol/L [1].in vivo: Compared to a
Find 51 Related Holders
Anhui Yuekang Kaiyue Pharmaceutical Co., Ltd.
China
China
API Registration Country
API Inactive
-
Founded in:
2012-09-11 -
Country:
China -
Address:
Industrial Avenue A, Economic Development Zone, Taihe County, Anhui Province -
Tax NO.:
913412220529496728 -
Registered Funds:
81 million yuan -
Website:
-
Email:
Recommended Suppliers of Vildagliptin
-
Chongqing Yuhan Technology Co., Ltd
CN1 YR
Contact Supplier -
Shaanxi Dideu Medichem Co. Ltd
CN1 YR
Contact Supplier -
bazayan Enterprises LLP
IN1 YR
Contact Supplier -
Echemi Pharmaceutical
CN1 YR
Contact Supplier -
HNB Biotech
CN1 YR
Contact Supplier